FDA To Internal Tissue Adhesive Firms: Come In Early With Details
This article was originally published in The Gray Sheet
Executive Summary
Device firms developing new internal tissue adhesive products should meet with the agency early on and provide detailed descriptions of their product and clinical protocol, agency officials said at a recent meeting.